Brief: Sprint Bioscience Q3 Operating Result Swings To Profit SEK 17.3 Million
Oct 27 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q3 NET SALES SEK 34.3 MILLION VERSUS SEK 5.2 MILLION YEAR
AGO
* Q3 OPERATING PROFIT SEK 17.3 MILLION VERSUS LOSS SEK 5.2
MILLION YEAR AGO
Source text for Eikon: ID:nWkr9cL2Fn
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program